Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 2 I, 1999, Pages 356-363

  Hoshino, Makoto ^a   Takahashi, Miki ^a   Takai, Yujiro ^a   Sim, JaeJoon ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Airway inflammation; Airway wall remodeling; Matrix metalloproteinase; Subepithelial basement membrane; Tissue inhibitors of metalloproteinase

Indexed keywords

BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; MATRIX METALLOPROTEINASE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BIOPSY TECHNIQUE; BRONCHUS BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN SYNTHESIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY;

EID: 0032845858     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70379-9     Document Type: Article

References (42)

1. Bousquet J, Chanez P, Lacoste JY, White R, Vic P, Godard P, et al. Asthma: a disease remodeling the airways. Allergy 1992;47:3-11.
2. Roche WR, Beasley R, Williams J, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-4.
3. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.
4. Woessner FJ Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
5. Matrisian LM. The matrix-degrading metalloproteinases. BioEssays 1992;14:455-63.
6. DiBattista JA, Pelletier J-P, Zafarullah M, Fujimoto N, Obata K, Martel-Pelletier J. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol Suppl 1995;43:123-8.
7. Vignola AM, Riccobono L, Mirabella A, Profita M, Chanez P, Bellia V, et al. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Grit Care Med 1998;158:1945-50.
8. Cataldo D, Louis R, Duysinx B, Lewalle JM, Noel A, Foidart JM, et al. Increased levels of galatinase B (MMP9) in the sputum of COPD and asthmatics [abstract]. Am J Respir Grit Care Med 1998;157:A502.
9. Bosse M, Chakir J, Rouabhia M, Boulet L-P, Audette M, Laviolette M. Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Grit Care Med 1999;159:596-602.
10. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-9.
11. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F Increased release of matrix metalloproteinase-9 in broncho alveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-91.
12. National Asthma Education Program Expert Panel. Guidelines for the diagnosis and management of asthma. National Asthma Education Program/Expert Panel Report. Bethesda (MD): National Institutes of Health/National Heart, Lung, and Blood Institute; 1991. Publication No. 91-3042.
13. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22.
14. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951-8.
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1988;136:225-44.
16. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80:600-6.
17. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP Complexes). J Histochem Cytochem 1984;32:219-29.
18. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-6.
19. Kodama S, Kishi J, Obata K, Iwata K, Hayakawa T. Monoclonal antibodies to bovine collagenase inhibitor. Collagen Rel Res 1987;7:341-50.
20. Tai P-C, Spry CJF, Peterson C, Venge P, Olsson L. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
21. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992;22:265-73.
22. Warnke RA, Pulford KAF, Pallesen G, Ralfkiaer E, Brown DC, Gatter KC, et al. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1. Am J Pathol 1989;135:1089-95.
23. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96.
24. Skalli O, Schurch W, Seemayer T, Lagace R, Montandon D, Pittet B, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-85.
25. Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-11.
26. Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy 1998;28:568-77.
27. Stricklin G, Welgus H. Human skin fibroblasts collagenase inhibitor: purification and biochemical characterization. J Biol Chem 1983;258:12252-8.
28. Stetler-Stevenson W, Krutzsch H, Liotta L. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase family. J Biol Chem 1989;264:17374-8.
29. Stricklin GP, Li L, Jancic V, Wenczak B, Nanney LB. Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol 1993;143:1657-66.
30. Hoshino M, Nakamura Y, Sim JJ, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783-8.
31. Clark SD, Kobayashi DK, Welgus HG. Regulation of the expression of tissue inhibitor of metalloproteinases and collagenase by retinoids and glucocorticoids in human fibroblasts. J Clin Invest 1987;80:1280-8.
32. Murphy G, Docherty AJP The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
33. Cheung NT, Taylor DJ, Clarke S, Fisher J, Jones PW, Mattey DL, et al. Effects of 6 months treatment on serum pro-stromelysin and pro-collagenase levels in rheumatoid arthritis (RA) patients [abstract], Br J Rheumatol 1996;35(Suppl 1):120.
34. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990;62:1189-204.
35. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acd Sci USA 1992;89:11789-93.
36. Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, et al. Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;62:1205-15.
37. Frish SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:16300-4.
38. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
39. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma, a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
40. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson S-A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992;145:890-9.
41. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990;142:832-6.
42. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.